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Abstract
Background: Tumors and complex tissues consist of mixtures of communicating cells that differ
significantly in their gene expression status. In order to understand how different cell types
influence one another's gene expression, it will be necessary to monitor the mRNA profiles of each
cell type independently and to dissect the mechanisms that regulate their gene expression
outcomes.
Results: In order to approach these questions, we have used RNA-binding proteins such as ELAV/
Hu, poly (A) binding protein (PABP) and cap-binding protein (eIF-4E) as reporters of gene
expression. Here we demonstrate that the epitope-tagged RNA binding protein, PABP, expressed
separately in tumor cells and endothelial cells can be used to discriminate their respective mRNA
targets from mixtures of these cells without significant mRNA reassortment or exchange.
Moreover, using this approach we identify a set of endothelial genes that respond to the presence
of co-cultured breast tumor cells.
Conclusion:  RNA-binding proteins can be used as reporters to elucidate components of
operational mRNA networks and operons involved in regulating cell-type specific gene expression
in tissues and tumors.
Background
Many recent studies have described the use of microarrays
to identify genes expressed in different types of cancers
(reviewed in [1,2]. Most of these transcriptomic studies
monitor the steady state levels of expressed mRNAs in
order to derive the "molecular signatures" of tumors [2].
However, the gene expression profile of a whole tumor
corresponds to the combined profiles of the different cell
types contained within it (e.g. endothelial cells, T-cells,
cancer cells, stromal cells, etc.). Moreover, the multiple
cell types present in a tumor or organ are interdependent
and exchange biochemical signals as a means of cell-cell
communication [3]. An important example of cell-cell
communication is evident in angiogenesis, the
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mechanism by which new blood vessels vascularize
tumors and other organs (reviewed in [4]). Monitoring
the dynamics of gene expression in each cell type of a
tumor during angiogenesis will advance understanding of
tumorigenesis as well as organogenesis, in general.
Methods have been devised to generate mRNA samples
from specific types of tumor cells. These include microdis-
section, laser capture (reviewed in [4-6], and cell sorting
based on specific membrane markers [7]. Here we demon-
strate that RNA-binding proteins can be used to isolate
mRNA populations representing total cell mRNA from
specific types of cells, as well as discrete mRNA subpopu-
lations that represent post-transcriptionally regulated sub-
sets of mRNAs that encode functionally related proteins.
We propose that these represent genes whose regulation is
important for tumor growth and maintenance.
RNA binding proteins play a key role in post-transcrip-
tional regulation, participating in splicing, mRNA trans-
port and localization, mRNA stability and translation (for
overview see ref. [8]). Our lab has devised biochemical
and immunological approaches to gene expression profil-
ing by using RNA-binding proteins as reporters of discrete
mRNA subsets in metazoan cells [8-10]. For example, we
identified subpopulations of mRNAs that are associated
with ELAV/Hu RNA-binding proteins that are expressed in
specific cell types [10]. While we and other labs have dem-
onstrated the isolation of mRNA subsets that are poten-
tially co-regulated using RNA binding proteins as
reporters of gene expression, methods have not been
described that provide information about coordinated
posttranscriptional regulation within specific types of
cells during tumorigenesis and development. Moreover,
because many different mRNA-binding proteins in spe-
cific cell types are known to interact with unique subpop-
ulations of mRNAs encoding functionally related proteins
[9-15] they can be informative of the dynamic effects of
cells on one another. Therefore, it will be necessary to
assess changes in gene expression that occur when cells
such as tumor cells and endothelial cells interact in order
to understand growth control and critical processes such
as angiogenesis.
In this study, we define a model system for using poly (A)
binding protein (PABP) to recover mRNAs from specific
cell-types in mixed cell cultures. Using this approach, we
were able to determine how the gene expression profiles
of endothelial cells change in response to the presence of
breast cancer cells. Among the advantages of this
approach are: a) no manipulations or treatments are
required prior to the preparation of cell extracts, b) the
recovered mRNA population can be identified directly
using genomic methods, and c) RNA binding proteins can
be engineered for expression in different cell types using
various molecular tags in order to discriminate cell-spe-
cific mRNA populations. These studies provide a method-
ological basis for creating mouse models in which
different types of cells within a tumor express RNA bind-
ing proteins to reveal unique populations of posttran-
scriptionally regulated mRNAs.
Results and Discussion
The goals of these experiments are to validate procedures
for the isolation and characterization of discrete mRNA
sub-populations associated with RNA binding proteins
expressed in specific cell types within a tumor or organ in
order to assess the responses of cells to their surroundings.
Earlier studies have shown that mRNA subpopulations in
single cell types reflect the functions of the RNA binding
proteins with which they associate and can provide key
information about post-transcriptional regulatory mecha-
nisms of gene expression [8-11,13,15-18]. In model
organisms, such information can be obtained by express-
ing epitope-tagged RNA binding proteins using tissue-spe-
cific promoters [19] or by using virus-specific receptors
(M.D.B., L.O.F.P. and J.D.K. unpublished). In this study
we demonstrate the feasibility of this approach by using
two different cell types in culture that each express specific
RNA binding proteins as reporters of gene expression
profiles.
Comparison of total mRNA of PY4.1 endothelial cells with 
their PABP-associated mRNA patterns
Microarray analysis was used to compare the gene expres-
sion profiles obtained using total RNA and PABP-associ-
ated RNA of PY 4.1 endothelial cells (Figure 1 and
supplementary data). These patterns were highly repro-
ducible and consistent. Very few if any qualitative differ-
ences were observed when comparing these mRNA
patterns indicating that the same set of expressed genes
was detected in both preparations. However, quantitative
differences were observed between some of the PABP-
associated mRNA levels and those of the total mRNA pop-
ulation (Figure 1 and supplementary data). Approxi-
mately 19% of the expressed mRNAs varied more than
two fold. In the case of the total mRNA profile (transcrip-
tome), the signal intensity reflects the steady-state level of
each mRNA, while the signal intensity of the PABP associ-
ated messages likely correlates with their translational
activity [20]. PABP is an essential RNA binding protein
that is highly conserved among eukaryotic organisms. It
mediates interactions between polyadenylated mRNA
sequences at the 3' ends of mRNAs and the eIF-4G protein
[21]. Interactions of eIF-4G with the cap-binding protein,
eIF-4E, are believed to circularize the mRNA and to pre-
pare it for association with ribosomes. Many studies have
shown that PABP is involved in activating the stability and
translation of mRNAs to which it is bound (reviewed in
[22,23], by protecting the poly (A) tail from exonucleaseMolecular Cancer 2004, 3:24 http://www.molecular-cancer.com/content/3/1/24
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attack [24], preventing mRNA decapping [25], by promot-
ing mRNA maturation [26] and by stimulating the initia-
tion of translation [20]. Most studies are in general
agreement that PABP functions as a translational activator
by facilitating the assembly of mRNAs and ribosomes. On
the average, a single PABP is expected to recognize approx-
imately fifteen adenylate residues, suggesting that approx-
imately ten molecules of PABP are bound to the average
mRNA that has a poly (A) stretch of 150–200 in length
[27].
Several reports indicate that substantial differences can be
found when comparing the steady state levels of mRNAs
(transcriptome) with proteins (proteome) in the same cell
population [28,29]. The accumulated levels of some pro-
teins and their corresponding mRNAs can vary by as much
as 30-fold [28-30]. The differential between steady state
levels of mRNA and protein are expected to be more dra-
matic under conditions in which post-transcriptional reg-
ulation plays a major role. For example, following T cell-
activation or during neuronal differentiation, transla-
tional control is thought to affect a significant proportion
of the proteomic outcome [31,32].
It is possible that gene expression profiles obtained by
immunoprecipitating mRNA-PABP complexes may reflect
the functional state of protein production from these
mRNAs [10]. For the purposes of this study, PABP is used
as a functionally relevant RNA-binding protein with
which to compare changes in bound mRNAs across gene
expression profiles.
Expression of tagged PABP does not interfere with cell 
growth
In order to compare mRNA profiles from mixed cell pop-
ulations, we prepared two different cell lines stably
expressing different epitope tagged PABPs. Figure 2 out-
lines the experimental approach. T98G human glioma
cells and PY4.1 mouse endothelial cells were co-cultured,
cell extracts were prepared and antibodies against PABP,
Flag-PABP and G10-PABP were used to immunoprecipi-
tate the mRNP complexes in order to generate mRNA pop-
ulations for gene expression analysis. Concerns that the
epitopes represented in the tags might affect the results
were addressed using PY4.1 cells stably expressing either
Flag-tagged PABP or G10-tagged PABP. Cell extracts from
both of the stable cell lines grown separately were pre-
pared and immunoprecipitated with the respective anti-
bodies. The two mRNA populations generated by this
procedure were compared using an RNAse protection
assay (RPA) and a microarray analysis. The results showed
no significant qualitative or quantitative differences
between these profiles in that 96% of the genes detected
by microarray were within 1.5-fold of one another (data
not shown).
A potential complication for this type of analysis is that
expression of a tagged-RNA binding protein, in this case
PABP, could affect cell growth. While these cell lines
appeared unaffected morphologically, the levels of PABP
in cell lines expressing tagged-PABP and respective control
cell lines were evaluated and compared by Western blot-
ting. No substantial change in overall PABP expression
was observed when expressing exogenous tagged PABP
(Figure 2C). This result was expected, since PABP has been
shown to inhibit the translation of its own mRNA by
binding to poly (A) sequences found in the 5' UTR. This
fortuitous auto-regulatory mechanism is believed to keep
the level of PABP constant in the cell, thereby avoiding
excessive overexpression [33].
No changes in cell growth or mortality of the cell lines
used in this study or in other cells lines expressing tagged-
PABP were observed. Moreover, the cell cycle kinetics of
T98G cells expressing Flag-PABP and cells that were sub-
sequently stimulated by serum addition were compared
to those of T98G cells containing the empty vector, pCM-
Vneo and no substantial differences were observed using
fluorescent cell sorting (Figure 2D). We conclude that
expression of neither the authentic PABP, nor the tagged-
Comparison of the gene expression profiles of total RNA  and PABP-associated mRNA populations Figure 1
Comparison of the gene expression profiles of total 
RNA and PABP-associated mRNA populations. Total 
RNA from PY4.1 murine endothelial cells and mRNA immu-
noprecipitated from cell extracts using anti-PABP serum 
were radiolabeled and hybridized on 1.2 mouse Atlas arrays 
(CLONTECH). The image overlay comparing total RNA with 
PABP-associated gene expression profiles was derived using 
the Atlas software with a global normalization showing quan-
titative, but not qualitative differences.
enriched at least 2X in PABP IP
enriched at least 2X in total RNA
less than 2X differencesMolecular Cancer 2004, 3:24 http://www.molecular-cancer.com/content/3/1/24
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A) Experimental design for sorting cell type specific mRNA populations using RNA binding proteins in mixed cell cultures Figure 2
A) Experimental design for sorting cell type specific mRNA populations using RNA binding proteins in mixed 
cell cultures. Two cell lines from two different species (murine endothelial PY4.1 and human glioma tumor T98G) are engi-
neered to express G10-tagged and FLAG-tagged PABP, respectively. Cell-type specific gene expression profiles are obtained 
from co-cultured cells or mixed cell extracts after immunoprecipitation with specific antibodies against the different tags. The 
RNA samples are phenol extracted, precipitated and subsequently analyzed by RPAs or microarrays. B) Western blots of 
cell lines expressing tagged-PABP. Immunoblots of extracts from T98G cells expressing Flag-PABP were probed with 
anti-Flag antibody, while extracts from PY4.1 and PY4.1 cells expressing G10-PABP were probed with anti-G10 antibody. Con-
trol blots of extracts of T98G and PY4.1 cells with anti-sera against PABP. C) Comparison between the overall levels of 
PABP of T98G cells and T98G cells expressing Flag-PABP. Immunoblots of extracts from T98G cells and T98G cells 
expressing Flag-PABP were probed with anti-sera against PABP and anti-α tubulin antibody, as a loading control. D) Compar-
ison of the cell cycle status of T98G and T98G expressing Flag-PABP cells – Cells were arrested at G0/G1 by serum 
deprivation and stimulated to re-enter the cell cycle by addition of serum. At the indicated times, aliquots of cells were proc-
essed for FACS analysis to determine the population distribution in G1, S, and G2 stages of the cell cycle. No differences 
between of the cell cycle of T98G cells and T98G cells expressing Flag-PABP were observed.
G10-PABP
retrovirus
Endothelial cell
Cancer cell
(human)
(mouse)
A)
Stable expression
of tag-PABP
Cell lysis and I.P.
with Flag Y and G10 Y Abs
AAAAAA
PABP Flag
Y
AAAAA
AAAAAA
PABP Flag
Y
AAAAA
PABP
G10
Y
PABP
Y
Analysis of the
mRNA populations
on microarrays
100-
75-
T98G-
FlagPABP
T98G
PY 4.1-
G10PABP
PY 4.1
Anti Flag mAb Anti G10 mAb Anti PABP serum
PY 4.1
T98G B)
Flag-PABP
retrovirus
D)
T
9
8
G
T
9
8
G
 
F
l a
g
- P A
B P
Time:     0h                           5h                        20h                            24h                        28h
G1
S
G2
Time:     0h                          5h                         20h                              24h                        28h
G1
S
G2
92.5%
2.7%
4.5%
82.1%
4.0%
4.8%
35.8%
49.6%
13.2%
17.1%
40.0%
40.3%
36.8%
7.8%
54.2%
87.9%
3.0%
8.7%
82.8%
3.8%
10.5%
38.6%
48.2%
13.0%
22.7%
35.2%
41.0%
43.5%
13.6%
40.5%
G10
Anti PABP serum
Anti α-tubulin
T98G-
FlagPABP
T98G C)Molecular Cancer 2004, 3:24 http://www.molecular-cancer.com/content/3/1/24
Page 5 of 12
(page number not for citation purposes)
PABP has untoward effects on the growth and homeosta-
sis of these cells.
PABP does not exchange between mRNAs in cell extracts
Early studies of PABP binding to mRNA indicated that a
dynamic exchange or hopping of PABP from mRNA to
mRNA might be an important aspect of its function
[27,34]. For the expression profiling methods described
above to be precise, it is critical to avoid post-lysis
exchange (or adventitious reassortment) of PABP with
mRNAs. In other words, does free mRNA in a cell extract
displace the mRNA originally bound to PABP during the
incubation period; or instead, does free PABP in an extract
exchange by binding to available mRNAs? PABP is a good
test model in this case because it has been suggested to
"hop" based on in vitro studies, and it is a highly abun-
dant RNA-binding protein. To examine these possibilities,
we added increasing amounts of competitor poly (A) RNA
with an average length of 550 nucleotides to lysates of
mouse endothelial PY4.1 and human glioma T98G cells.
After immunoprecipitation with anti-PABP serum,
mRNAs were isolated from the pellets and analyzed using
a highly sensitive multi-probe RNase Protection Assay
(RPA) as described previously [10]. Figure 3 shows that
the mRNAs originally bound to PABP were not displaced
by the competing poly (A) RNA even at concentrations as
high as 1000 fold excess. The inability of free poly (A)
RNA to compete bound PABP off of endogenous mRNA
reflects a stable interaction between PABP and endog-
enous mRNA. These data suggest that exchange of mRNA
into PABP RNPs is not likely to distort gene expression
profiles obtained by immunoprecipitating PABP, and in
addition, this observation is not compatible with a previ-
ous "hopping model" for PABP [27].
We have also addressed the potential problem of having a
pool of free PABP in an extract that could be available to
bind mRNA during incubation. Sucrose gradient analysis
indicated that this is very unlikely since the majority of
PABP was found in heavy polysomes and associated with
mRNA, while only a small percentage was found in the
upper portion of the sucrose gradients (H.S. and J.D.K.,
unpublished data). In total, these results demonstrate that
reassortment of PABP in these cell extracts was not a sig-
nificant limitation to using PABP RNPs for gene expres-
sion profiling of bound mRNAs.
As noted above, it has been suggested that yeast PABP uses
a "hopping" mechanism in vivo by moving from RNA to
RNA [27,34]. While this experiment is not a direct test of
that hypothesis, these data are not consistent with a hop-
ping or exchange of PABP among the mRNAs in our cell
extracts, but suggest instead that PABP forms a stable RNP
complex with polyadenylated transcripts.
Detection of cell-specific mRNAs using epitope-tagged 
PABP
The question of whether reassortment of PABP occurs
among mRNAs in cell extracts was also examined using
lysates from mixed mouse and human cells. We used two
different cell lines, murine endothelial PY4.1 and human
glioblastoma T98G, that express G10-PABP and Flag-
PABP, respectively (Figure 2B). T98G cells have a volume
approximately 3 to 4 times larger than PY4.1 cells. These
cell lines were co-cultured in an approximate 1:1 cell ratio
and subsequently lysed, or in separate experiments,
lysates of each were mixed at equivalent amounts of total
protein prior to immunoprecipitation. Both approaches
gave the same results. Using the G10 antibody to precipi-
Reassortment of mRNA and PABP was not detected in cell  lysates Figure 3
Reassortment of mRNA and PABP was not detected 
in cell lysates. The potential for displacement of PABP was 
tested by adding increasing amounts (0–1500 µg) of pure 
competitor poly (A) to 400 µl of cell lysates of PY4.1 and 
T98G cells prior to incubation with antibody-coated (anti-
PABP) beads. Following immunoprecipitation, mRNAs were 
isolated from the pellets and analyzed using the RNase Pro-
tection Assay (RPA) mouse angiogenesis (mAngio) and 
human tumor suppressor (hTS1) multi-probe sets. Unpro-
tected RNA probes were used to identify the nature of the 
different sized protected fragments. The experiment shows 
that the interaction between PABP and the endogenous 
mRNA targets cannot be disrupted by competing poly (A) 
RNA.
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tate only PY4.1 mRNAs and Flag antibody to precipitate
T98G mRNAs we were able to examine the separate pop-
ulations using a multiprobe RPA (Figure 4). Thus, by mix-
ing a human (T98G) and a murine (PY4.1) cell line we
could take advantage of the species-specific RPA probe
sets. Given our interest in tumor angiogenesis, we used
mouse angiogenesis (mAngio) and human tumor
suppressor (hTS1) RPA probe sets after they were tested
for cross species hybridization. Both probe sets showed
good specificity of discrimination with the exception of
the L32 and GAPDH control genes as expected (Figure 4A
and 4B). In Figure 4C and 4D, it is apparent that the same
expressed genes were detected whether using total RNA, or
mRNA obtained by immunoprecipitation with anti-PABP,
anti-Flag or anti-G10 antibodies. Extracts from mixed cell
lines were immunoprecipitated and analyzed using both
human and mouse probe sets (Figure 4E,4F and 4G). Both
mouse and human mRNAs were detected when anti-PABP
rabbit serum was used to precipitate both endogenous
and exogenous PABP, while immunoprecipitations with
anti-G10 and anti-Flag antibodies enriched the mRNA
population for each species with only minor background
from the other species. While the discrimination obtained
in these experiments was excellent, a low degree of back-
ground due to non-specific binding of mRNA to the agar-
ose beads was consistently observed even in the absence
of antibody.
Analysis of PABP-associated mRNA populations using 
microarrays
In order to evaluate the degree of mRNA enrichment over
background using a genome–wide methodology, we ana-
lyzed immunoprecipitated mRNAs from mixed cell popu-
lations on CLONTECH Atlas arrays. We first tested these
arrays for cross species hybridization using total RNA and
it was minor (data not shown). The mouse RNA on
human Atlas arrays did not show any detectable cross
hybridization signal, while the human RNA on mouse
Atlas arrays showed a small percent (2–3%) of cross
hybridizing mRNAs (Figure 5B, blue squares).
To identify the PABP-associated mRNAs in the T98G Flag-
PABP and PY4.1 G10-PABP cells, extracts were prepared as
described above, followed by immunoprecipitation with
either anti-Flag or anti-G10 antibodies. The mRNA popu-
lations generated by both immunoprecipitations were
analyzed on human and mouse 1.2 Atlas arrays. Cross-
species hybridization was monitored and genes showing
cross-species reactivity were eliminated from considera-
tion. A comparison of Flag versus G10 PABP-associated
mRNAs was performed to assess the degree of enrichment.
In an average experiment for the mouse genes, 91 % (184
out of 202 detected genes) were enriched at least 4 fold in
the G10 PABP population when compared to the Flag
PABP population. For the human genes, 82.4 % (122 out
if 148) were enriched at least 4 fold in the Flag PABP pop-
ulation in relation to the G10 PABP population (Figure 5
and supplementary data).
Changes in gene expression induced by co-cultivation of 
PY4.1 endothelial cells with 4T1 breast cancer cells
Having demonstrated that the approach we described
using PABP can be used to efficiently recover cell type spe-
cific mRNAs from mixed cell types, we addressed the con-
sequences of cell-cell communication and changes in gene
expression that were induced in the endothelial cells by
co-cultivation with the tumor cell. The goal of these exper-
iments is to gain insight into how endothelial cells
respond to the presence of cancer cells in cell culture as a
first approximation of changes in gene expression that
may be involved in early stages of angiogenesis. We used
two murine cell lines, the PY4.1 line described above and
a 4T1 breast tumor cell line that can produce tumors and
spread by metastasis in nude mice.
Figure 6 represents a schematic view of two branches of
our experimental strategy. In the first line of inquiry,
PY4.1 cells stably expressing Flag-PABP and 4T1 cells were
co-cultured. The number of plated cells of each type was
calculated based upon measurements of their different
growth rates. After 48 hours the co-cultured cells reached
confluence. Approximately 50% of the petri dish surface
was covered with PY4.1 cells and 50% was covered with
4T1 cells. Cells were harvested and extracts were prepared
as described above. In the second line of inquiry, the two
cell types were plated separately. Cells were harvested after
48 hours of incubation, the extracts were prepared, and
mixed proportionally to those used in the first experimen-
tal line of investigation. Subsequently, extracts from the
co-cultured and the mixed cells were immunoprecipitated
with anti-Flag antibodies and mRNAs analyzed on micro-
arrays. The comparison between the two mRNA popula-
tions (co-culture versus mix) was used to detect changes in
the gene expression profile of PY4.1 cells as a response to
the presence of 4T1 cells. In a separate experiment, a
comparison between PY4.1 total RNA labeled with Cy3
and Cy5 was performed to rule out dye bias (not shown).
As expected, the great majority of the genes expressed in
PY4.1 cells were not altered in their levels of expression
while in co-culture. Of interest, a small number of genes
were consistently upregulated in four independent exper-
iments. To assess the consistency of the fold change, we
plotted the p-value (from modified t-test) against the
average fold change (Figure 7). A 'volcano plot' summa-
rizes both the magnitude of change and the correspond-
ing statistical significance for all genes. We sorted the
candidate genes according to their p-values (Table 1), and
the top-20 genes were identified and are listed along with
comments concerning their biological function(s). [SeeMolecular Cancer 2004, 3:24 http://www.molecular-cancer.com/content/3/1/24
Page 7 of 12
(page number not for citation purposes)
RNase Protection Assay (RPA) of mRNAs from mixed mouse and human cell lines Figure 4
RNase Protection Assay (RPA) of mRNAs from mixed mouse and human cell lines. Species specificity of multi-
probe RPAs using: A) the human tumor suppressor probe set (hTS1), and B) the mouse angiogenesis RPA probe set (mAn-
gio), was verified using total RNA extracted from murine PY4.1 cells and human T98G cells. Unprotected RNA probes were 
used to identify the nature of the different sized protected fragments. C) RPA gene expression profile of PY4.1 cells expressing 
G10-PABP obtained with total RNA and with mRNA derived from immunoprecipitations with anti-PABP serum or anti-G10 
antibody D) RPA gene expression profile of T98G cells expressing Flag-PABP obtained from total RNA and from mRNA 
derived from immunoprecipitations with anti-PABP serum or anti-Flag antibody. E, F and G) Mixed extracts from cells 
expressing T98G Flag-PABP and PY4.1 G10-PABP were immunoprecipitated with anti-PABP serum or anti-Flag or anti-G10 
antibodies. The mRNA populations generated by immunoprecipitations were analyzed with RPA of both the mouse angiogen-
esis (mAngio) and the human tumor suppressor probe (hTS1) sets. GAPDH and L32 are controls in both probe sets and show 
cross species hybridization. The asterisk in B and G also indicate a band resulting from cross species hybridization. The exper-
iments indicate that species-specific mRNA populations can be isolated and quantified by the use of distinct tagged-PABPs.
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Supplementary Data for the complete microarray analysis
– http://www.dbsr.duke.edu/pub/pabp]. Several of the
genes present in this population are gene expression regu-
lators that fall into two major categories: RNA binding
proteins and DNA binding proteins/transcription factors.
We expected to find gene expression regulators as part of
an early response to cell surface interactions or secreted
factors from the other cell line. As with any biochemical
cascade event, changes in the expression of global regula-
tors as well as structural genes (such as those encoding
membrane or cytoskeletal proteins) often precede
downstream alterations in the expression of other
important genes. Among the RNA binding proteins iden-
tified in our screen were stem-loop binding protein, a
highly conserved RNA binding protein that binds a stem
loop structure in the 3'UTR of histone mRNAs and is
required for both processing and translation of histone
messages [35], Brul4, the mouse homologue of Drosophila
bruno, a translation repressor which functions at the early
steps of embryogenesis [36], and quaking, described as a
key gene involved in the myelination of the central nerv-
ous system and other regulatory functions [37]. It should
be noted that we did not identify PY4.1 genes whose
expression decreased as a response to the presence of 4T1
cells.
Discrimination of the gene expression profiles of mixed  human and mouse cell lines using microarrays Figure 5
Discrimination of the gene expression profiles of 
mixed human and mouse cell lines using microar-
rays. Cell extracts from T98G Flag-PABP and PY4.1 G10-
PABP cells were prepared, mixed and immunoprecipitated 
with both anti-Flag and anti-G10 antibodies. The mRNA pop-
ulations generated by both immunoprecipitations were ana-
lyzed on human and mouse 1.2 CLONTECH arrays. When 
anti-Flag antibodies were used, the T98G mRNA population 
was enriched in relation to the PY4.1 mRNA population. 
When anti-G10 antibodies were used, the PY4.1 mRNA pop-
ulation was enriched in relation to the T98G mRNA 
population.
A)
B)
human arrays
mouse arrays
enriched at least 4X in Flag IP
enriched at least 4X in G10 IP
cross species hybridization
less than 4X enrichment
Effects of co-cultivated mouse tumor cells on gene expres- sion profile of mouse endothelial cells Figure 6
Effects of co-cultivated mouse tumor cells on gene 
expression profile of mouse endothelial cells. PY4.1 
cells expressing Flag-PABP and 4T1 cells were grown either 
separately or together in a co-culture. Cell extracts from the 
co-culture and from a mixture of the monocultures were 
prepared. Immunoprecipitation of extracts with anti-Flag 
antibodies generated two distinct PY4.1 cells mRNA popula-
tions that were compared by microarray. The comparison 
revealed PY4.1 cellular genes that changed their gene expres-
sion profile in response to presence of 4T1 breast cancer 
cells.
+
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The presence of several RNA binding proteins among the
top-20 genes affected by co-cultivation may result in
downstream effects on gene expression, and we plan to
examine the target mRNAs of these RNA binding proteins
in endothelial cells. This should help elucidate additional
post-transcriptional pathways and networks regulating
cell growth mechanisms and tumorigenesis [9].
Conclusion
This study describes changes in the gene expression profile
of an endothelial cell when co-cultivated with a tumor cell
by isolating ribonucleoprotein complexes and identifying
their associated mRNAs using genomic arrays. Moreover,
it presents a model system that can be used to elucidate
post-transcriptional operons in specific types of cells by
using various RNA binding proteins from mixed cell cul-
tures as a novel approach to understanding how cell-cell
communication affects gene expression during tumori-
genesis and organogenesis.
Methods
Cell lines and media
Murine endothelial PY4.1 cells were kindly provided by
Dr. Christopher Kontos, Duke University Medical Center.
Human gliobastoma T98G and murine breast cancer 4T1
cells were obtained from American Type Culture
Collection. All cell lines were maintained in DMEM
Medium (Gibco) supplemented with 10% Fetal Bovine
serum.
Constructs and stable cell lines
The ORF of human PABP I containing the Flag tag (GAC-
TACAAGGACGACGATGACAAG) or the G10 tag (CCAC-
CATGGCT AGCATGACTGGTGGACAGCAAATGGGT) at
the 5' end was cloned into the pCMV-Neo retroviral vector
[38]. Stable lines expressing the Flag-PABP (T98G and PY
4.1 cells) and the G10-PABP (PY 4.1 cells) were obtained
according the protocol described in the Pantropic Retrovi-
ral Expression System (Clontech).
Antibodies
Monoclonal anti-G10 antibodies were obtained as previ-
ously described [39]. Antibodies against Flag and α-tubu-
lin were obtained from SIGMA. A PABP carboxy-terminal
(last 172 amino acids) was prepared by cloning a PCR
product into the pGEXCS expression vector. The protein
was purified by their affinity to glutathione beads (Amer-
sham Biosciences). The purified proteins were dialyzed
against 1 × PBS, 20% glycerol and sent to COVANCE Inc.,
where a rabbit was immunized.
Protein preparation and Western analysis
Protein extracts were prepared from T98G and PY4.1 cell
lines by homogenization in polysomal lysis buffer [10].
50 µg of extract were fractionated by electrophoresis in
10% polyacrylamide-SDS Laemmli gels. Proteins were
transferred to nitrocellulose membranes using a transfer
cell (Bio-Rad). After blocking with 5% nonfat milk in PBS-
Tween 20 buffer, the membranes were incubated with
anti-PABP rabbit serum (1:10,000 dilution), anti-Flag
antibody (1:1,500 dilution) or anti-G10 antibody
(1:10,000 dilution). Anti-rabbit or anti-mouse HPC IgGs
(Amersham Biosciences) were used as secondary antibod-
ies at a 1:3000 dilution. Blots were developed using an
ECL detection kit (Amersham Biosciences) and exposed to
film.
Cell cycle experiments
Analysis of the cell cycle of T98G cells was performed as
described [40].
Immunoprecipitation of mRNP complexes from cell 
lysates
Cell lysates and immunoprecipitation of mRNP com-
plexes were essentially performed as described [41]. Poly-
adenylated RNA (free poly-A) used in competition
experiments was obtained from Amersham Biosciences.
RNase Protection Assay
Total or immunoprecipitated RNAs were assayed by
RNase protection by using the PharMingen Riboquant
assay according to the manufacturer's recommendations
(45014K). mAngio-1 (mouse angiogenesis) and hTS1
(human tumor suppressor) template sets were used
(551418 and 556161, respectively). Protected riboprobe
"Volcano" plot of p-value versus fold change in expression  level Figure 7
"Volcano" plot of p-value versus fold change in 
expression level. Dashed line indicates the cutoff of the 
top 20 enriched genes shown in Table 1.
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fragments were visualized on a phosphorimaging screen
(Molecular Dynamics). Phosphorimages were scanned by
using the Molecular Dynamics STORM 860SYSTEM at
100  µm resolution and analyzed by using Molecular
Dynamics IMAGE QUANT software (version 5.0).
Clontech microarrays, probing and analysis
cDNA array analysis was performed by using Atlas Mouse
and Human 1.2 Arrays (CLONTECH). Probing of cDNA
arrays was performed as described in the CLONTECH
Atlas cDNA Expression Arrays User Manual (PT3140-1).
Reverse-transcribed probes were radiolabeled with 32P α-
dATP (Amersham Biosciences). After hybridization, the
Table 1: List of the top 20 PY4.1 genes that were upregulated in response to the presence of 4T1 tumor cells. Genes are classified 
according to their biological function. Gene expression regulators (GR). Genes involved in metabolism (M). Genes related to cell cycle 
or cell division (C). Genes encoding structural proteins (S). Other genes (O).
Name, classification gbID fold P value biological function
1-Heterogeneous nuclear ribonucleoproteinH1, (G R) NM_021510 2.6 6.40E-06 RNA binding, RNA processing and modification
2-High mobility group box 1, (G R) NM_010439 2.7 9.78E-06 DNA binding, nitric oxide biosynthesis, 
inflammation mediator, cell differentiation
3-Prothymosinalpha, (C) NM_008972 3.7 1.38E-05 cell proliferation, cell division
4-RIKEN cDNA2610016F04 gene, (G R) AK009120 2.6 4.59E-05 putative DNA binding, transcritionfactor
5-ATPase, H+ transporting, (M) NM_024173 1.8 4.92E-05 hydrogen-exporting, ATPaseactivity, 
phosphorylativemechanism
6-RIKEN cDNA2510010F10 gene, (O) AF215660 1.8 7.45E-05 described as a carnitinedeficiency-associated gene
7-Stem-loop binding protein, (G R) NM_009193 2.1 7.88E-05 RNA binding, histonemRNA processing
8-Quaking, (G R) NM_021881 1.9 7.79E-05 RNA binding, participates in myelination
9-RIKEN cDNA2410004I17 gene, (O) AK010391 2 8.26E-05 unknown
10-Purinerich element binding protein A, (G R) NM_008989 2.8 8.95E-05 DNA and RNA binding, association with rough 
endoplasmic reticulum, postnatal brain development
11-Similar to isopentenyl-diphosphatedelta isomerase, (M) BC004801 3 9.80E-05 cholesterol biosynthesis, steroid biosynthesis
12-P53 apoptosis effectorrelated to Pmp22, (O) NM_022032 2.4 1.11E-04 induction of apoptosis
13-Tumor differentially expressed 1, like, (S) NM_019760 2 1.17E-04 plasma membrane
14-RIKEN cDNA5830409B12 gene, (S) AK017914 7.6 9.73E-05 putative cytoskeleton associated protein
15-G7e protein, (S) NM_033075 2 1.42E-04 resembles viral envelope genes
16-Procollagenlysine, 2-oxoglutarate 5-dioxygenase 2, (M) NM_011961 2.8 1.43E-04 protein metabolism
17-Receptor-like tyrosine kinase, (M) L21707 1.7 2.08E-04 ATP binding, kinaseactivity
18-RIKEN cDNA4930506D01 gene, (G R) BC006745 2.8 1.77E-04 putative transcription factor
19-MusmusculusBRUL4 (Brul4) mRNA, (G R) AF314173 5.8 1.91E-04 RNA binding, translation regulator
20-CyclinI, (C) NM_017367 2.3 1.67E-04 cell cycle, cyclin-dependent protein kinaseregulator 
activity
relevant references
1-none
2-Gastroenterology. 2002. 123:790–802; J LeukocBiol. 2002. 72:1084–1091
3-Peptides. 2000. 21:1433–1446; IntJ Biochem Cell Biol. 1999. 31:1243–1248.
4-none
5-J BiolChem. 2002. 277:36296–36303; Gene. 2003. 302: 147–153.
6-Biochim BiophysActa. 2002. 1577:437–444.
7-J. Cell Sci. 2002. 115: 4577–4586.
8-Neuron. 2002. 36:815–829; Nucleic Acids Res. 2003.31:4616–4624
9-none
10-J BiolChem. 2002.277:37804–37810; Mol Cell Biol. 2003. 23:6857–6875
11-J Mol Evol. 2003. 57: 282–291.
12-Genes Dev. 2000. 14: 704–718.
13-J Exp Biol. 2000. 203:447–457.
14-none
15-Genomics. 1996. 15:5–12
16-J BiolChem. 2003. 278:40967–40972.
17-none
18-J Immunol. 1995. 154:1157–1166; Proc NatlAcadSciU S A. 1992. 89:11818–11822.
19-CytogenetGenome Res. 2002.97:254–260.
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array membrane was washed and the results were visual-
ized on a phosphorimaging screen (Molecular Dynam-
ics). Phosphorimages were scanned by using the
Molecular Dynamics STORM 860SYSTEM at 100 µm res-
olution and stored as .gel files. Images were analyzed by
using ATLASIMAGE 2.01 software (CLONTECH). Global
normalization was used when arrays being compared had
approximately the same number of positive hits.
Printed oligo arrays, probing and analysis
Printed oligo arrays using the Operon Mouse Oligo set
version 2.0 (16,423 genes) were produced by the Duke
Microarray Core Facility. Protocols used for preparation of
slides, labeling, amplification, hybridization and scan-
ning are described in http://www.mgm.duke.edu/
genome/dna_micro/core/protocols.htm.
GenePix data were normalized with pin-tip specific lowess
normalization [42]. Differentially expressed genes were
identified with a moderated t-test, which shrinks the esti-
mated sample variances towards a pooled estimate [43].
This moderated t-test is more robust when the number of
arrays is small. The candidate gene list is sorted by the p-
value. All calculations were conducted using the biocon-
ductor package [44].
List of abreviations
ELAV – embryonic lethal abnormal vision
RPA – RNase Protection Assay
PABP – Poly A binding protein
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